| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Share Buyback Program: transactions conducted between 17 May 2024 and 23 May 2024 | 2 | CNMV | ||
| Di | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Publication of the announcement of the call to the General Shareholders' Meeting and the documentation related thereto. | 1 | CNMV | ||
| 17.05. | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Share Buyback Program: transactions conducted between 10 May 2024 and 16 May 2024 | 3 | CNMV | ||
| 10.05. | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Share Buyback Program: transactions conducted between 2 May 2024 and 9 May 2024 | 1 | CNMV | ||
| 09.05. | AZURE MINERALS LIMITED: Appendix 3Z - Rovira | 2 | ASX | ||
| 09.05. | AZURE MINERALS LIMITED: Appendix 3Y - Rovira | - | ASX | ||
| 08.05. | LABORATORIOS FARMACEUTICOS ROVI, S.A.: The Company announces the decision of its Board of Directors to convene the Ordinary General Shareholders' Meeting. | 3 | CNMV | ||
| 30.04. | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Share Buyback Program: transactions conducted between 26 April 2024 and 30 April 2024 | 1 | CNMV | ||
| 26.04. | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Share Buyback Program: transactions conducted between 19 April 2024 and 25 April 2024 | 1 | CNMV | ||
| 24.04. | GSK, Lundbeck, ROVI: Three Journeys of Unified Pharma Events Management | 9 | Pharmaceutical Technology | ||
| 19.04. | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Share Buyback Program: transactions conducted between 12 April 2024 and 18 April 2024 | 2 | CNMV | ||
| 12.04. | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Share Buyback Program: transactions conducted between 5 April 2024 and 11 April 2024 | 1 | CNMV | ||
| 05.04. | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Share Buyback Program: transactions conducted between 28 March 2024 and 4 April 2024 | 1 | CNMV | ||
| 02.04. | LABORATORIOS FARMACEUTICOS ROVI, S.A.: The Company releases the press release related to the FDA's approval of Risvan® (Risperidone ISM®) as a treatment for schizophrenia | 4 | CNMV | ||
| 29.03. | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Share Buyback Program: transactions conducted between 22 March 2024 and 27 March 2024 | 1 | CNMV | ||
| 27.03. | Anheuser-Busch InBev gets grant for a patent for a roving beverage dispensing device | 5 | Just Drinks | ||
| 22.03. | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Share Buyback Program: transactions conducted between 15 March 2024 and 21 March 2024 | 1 | CNMV | ||
| 15.03. | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Share Buyback Program: transactions conducted between 8 March 2024 and 14 March 2024 | 3 | CNMV | ||
| 15.03. | Sonic, Angry Birds 5 game crossover event unites Sega and Rovio | 1 | VentureBeat | ||
| 14.03. | Laboratorios Rovi, Insud Pharma and Ministry of Science form partnership to research advanced therapies | 3 | thecorner.eu |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 434 |
| EVOTEC | 364 |
| NEL | 265 |
| TUI | 247 |
| BAYER | 221 |
| GAMESTOP | 209 |
| BIONTECH | 178 |
| TESLA | 154 |
| PLUG POWER | 146 |
| BYD | 142 |
| RHEINMETALL | 142 |
| SUPER MICRO COMPUTER | 114 |
| COMMERZBANK | 113 |
| VOLKSWAGEN | 101 |
| DEUTSCHE BANK | 99 |
| MERCEDES-BENZ | 96 |
| SIEMENS ENERGY | 95 |
| DEUTSCHE LUFTHANSA | 91 |
| THYSSENKRUPP | 79 |
| AIXTRON SE | 77 |
| BASF | 76 |
| AMD | 75 |
| ALLIANZ | 71 |
| RWE | 71 |
| DEUTSCHE TELEKOM | 66 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
